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Abstract
Background: Obesity is genetically heterogeneous and 
highly heritable, although polymorphisms explain the 
phenotype in only a small proportion of obese children. 
We investigated the presence of copy number variations 
(CNVs) in “classical” genes known to be associated with 
(monogenic) early-onset obesity in children.
Methods: In 194 obese Caucasian children selected for 
early-onset and severe obesity from our obesity cohort we 
screened for deletions and/or duplications by multiplex 
ligation-dependent probe amplification reaction (MLPA). 
As we found one MLPA probe to interfere with a polymor-
phism in SIM1 we investigated its association with obesity 
and other phenotypic traits in our extended cohort of 2305 
children.
Results: In the selected subset of most severely obese 
children, we did not find CNV with MLPA in POMC, LEP, 
LEPR, MC4R, MC3R or MC2R genes. However, one SIM1 
probe located at exon 9 gave signals suggestive for SIM1 
insufficiency in 52 patients. Polymerase chain reaction 
(PCR) analysis identified this as a false positive result 
due to interference with single nucleotide polymorphism 
(SNP) rs3734354/rs3734355. We, therefore, investigated for 
associations of this polymorphism with obesity and meta-
bolic traits in our extended cohort. We found rs3734354/
rs3734355 to be associated with body mass index-stand-
ard deviation score (BMI-SDS) (p = 0.003), but not with 
parameters of insulin metabolism, blood pressure or food 
intake.
Conclusions: In our modest sample of severely obese chil-
dren, we were unable to find CNVs in well-established 
monogenic obesity genes. Nevertheless, we found an 
association of rs3734354 in SIM1  with obesity of early-
onset type in children, although not with obesity-related 
traits.
Keywords: children; copy number variations; genetic vari-
ants; obesity; SIM1.
Introduction
Obesity is etiologically heterogeneous. The assumed her-
itability for obesity-related phenotypes is estimated to be 
above 60% [1], although it varies to a large extent [2]. The 
effects of single nucleotide polymorphisms (SNP) have 
been investigated extensively under the assumption that 
common diseases are attributable to common variants. 
However, common loci identified by genome-wide asso-
ciation studies (GWAS) were able to explain around 3% of 
body mass index (BMI) variance only [3]. This gap moved 
the focus towards copy number variations (CNVs) that are 
estimated to account for about 18% of heritable variance 
in gene expression [4]. Recent findings started to elucidate 
the role of CNVs in non syndromic diseases and metabolic 
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disorders, as was shown for an association of a common 
deletion near the neuronal growth regulator 1 (NEGR1) 
with BMI [5], large CNVs (>1 Mb) were found to be overrep-
resented in obese cases vs. control subjects [6], and CNVs 
to be associated with BMI and gene expression of AMY1 
as well as serum amylase enzyme levels [7]. Also, asso-
ciations with syndromic forms of obesity were recently 
reported for CNVs on chromosome 16 in adults [8], and are 
well described for specific entities such as Charcot-Marie-
Tooth [9], Angelman [10] and Prader-Willi syndrome [11], 
attention deficit hyperactivity disorder [12] or autism [13].
We hypothesized that CNVs around obesity candi-
date genes might explain the gap between expected and 
measured heritability for BMI and contribute to BMI varia-
tion, potentially causing severe early-onset obesity. In this 
regard, particularly genes with rare variants causing mono-
genetic early-onset obesity, such as melanocortin receptors 
(MC4R, MC3R, MC2R) [14, 15], leptin receptor (LEPR) [16], 
single minded homolog 1 (SIM1) [17], proopiomelanocor-
tin (POMC) [18] would be interesting. As only children are 
less affected by comorbidities, medication and environ-
mental factors, they are an attractive population to iden-
tify contributing genetic determinants in such a complex 
polygenic disease like obesity. We assumed that children 
with a high BMI-standard deviation score (SDS) have a 
higher risk for gene dosage variation and we consequently 
selected patients with the utmost BMI-SDS of our cohort. 
In this subset, we screened for CNVs in POMC, LEP, LEPR, 
MC4R, MC3R, MC2R and SIM1 gene regions using multiplex 
ligation-dependent probe amplification (MLPA) technique, 
which has been proven to be efficient and robust [19] and 
was previously successfully applied for screening of vari-
ations in children with idiopathic mental retardation [20], 
autism [21] and obsessive-compulsive disorder [22].
Subjects and methods
Cohort design
We selected 194 Caucasian children and adolescents (86  male, 
108 female) with a BMI of ≥2 SDS (mean BMI was 2.89 ± 0.41 SDS) 
recruited from our obesity clinic for the initial CNV screen. For a fur-
ther description see Table 1.
To validate our findings on the SIM1 polymorphism rs3734354, we 
extended our cohort with exome chip data of a further 1074 obese chil-
dren as well as 1231 lean controls, altogether 2305 children (Table 2).
A comprehensive metabolic work-up including lipid profiles, an 
oral glucose tolerance test and blood pressure measurements were 
collected. All children were free of severe diseases and of medica-
tions. We excluded participants that had one of the following charac-
teristics: chromosome disorders (Klinefelter’s syndrome, trisomia), 
other genetic disorders (Prader-Willi syndrome, Bardet-Biedl syn-
drome), administration of valproic acid or metformin. Height was 
measured to the nearest of 0.1 cm and weight to the nearest of 0.1 kg 
using a digital balance. BMI data were standardized to age and sex 
of the children applying German reference data [23], and is given 
as BMI-SDS or z-score. To classify overweight (BMI between 1.23 
and 1.88 SDS) and obesity (BMI ≥ 1.88 SDS) we applied consensus 
guidelines of the German Working Group for Pediatric Obesity [24]. 
Blood samples were obtained in the fasted state at 08:00  am and 
were immediately centrifuged, aliquoted and stored at −80 °C. Blood 
lipids, glucose and insulin were measured by a certified laboratory 
applying standard clinical biochemistry methods.
Written informed consent was obtained from all guardians and 
children older than 12 years. Both studies were approved by the Ethi-
cal Committee of the University of Leipzig.
MLPA
We used a kit nr. P220 by MCR-Holland (Amsterdam, The Nether-
lands) covering our target genes, probes are listed in Supplemental 
Table 1. A total of 100 ng of genomic DNA was used for the reaction 
which was carried out with MLPA-SALSA kit by MCR-Holland accord-
ing to the manufacturer’s instructions. To measure the probe ampli-
tude we injected polymerase chain reaction (PCR) products into 
capillary electrophoresis on an ABI PRISM 7500  sequence detector 
(Applied Biosystems Inc., Foster City, CA, USA) and extracted the 
Table 1: Demographic characteristics of patients analyzed for copy 
number variations.
Variable Mean ± SD [min–max]
n (Girls/boys) 194 (108/86)
Age, years 11.0 ± 3.8 [3–18]
BMI, kg/m2 31.0 ± 5.3 [21–47]
BMI-SDS 2.89 ± 0.41 [2.2–4.8]
WHR 0.89 ± 0.1 [0.73–1.49]
PH 2.69 ± 1.8 [1–6]
Range is given in squared brackets. BMI, body mass index; WHR, 
waist-to-hip ratio; PH, Tanner pubertal state.
Table 2: Demographic characteristics of patients analyzed for SIM1 
variant rs3734354.
Variable Mean ± SD [min–max]
n (Girls/boys) 2305 (1182/1123)
Age, years 11.3 ± 3.36 [0.2–17.99]
BMI, kg/m2 22.4 ± 6.55 [11.4–56]
BMI-SDS 1 ± 1.48 [−4.4 to 4.9]
Height SDS 0.34 ± 1.2 [−6 to 4.8]
WHR 0.85 ± 0.08 [0.58–1.49]
PH 2.53 ± 1.7 [1–6]
Range is given in squared brackets. BMI, body mass index; WHR, 
waist-to-hip ratio; PH, Tanner pubertal state.
Bereitgestellt von | Universitaetsbibliothek Leipzig
Angemeldet | melanie.penke@medizin.uni-leipzig.de
Heruntergeladen am | 23.06.17 09:11
Windholz et al.: Copy number variations in obese children      509
data using GeneMapper (Applied Biosystems). For data normaliza-
tion, based on a healthy, non obese control, the relative peak height 
(RPH) method recommended by MRC-Holland was used [25, 26]. 
Peak heights below 0.75 were considered as deletions and above 1.30 
as duplications. Positive samples were repeated twice. Repeatedly 
found deletions were confirmed twice with MLPA and with PCR fol-
lowed by sequencing to verify the alteration and to make sure that 
the MLPA probe properly bound to its binding site.
Genotyping SIM1
To verify the expected deletion in SIM1 exon 9  we used DNA, for 
which MLPA indicated a homozygous loss of both alleles and per-
formed PCR with four overlapping primers flanking the exon 9 MLPA 
probe binding site (see Supplemental Figure 1). Genomic DNA was 
extracted from peripheral leukocytes using a Qiagen DNA extraction 
kit (Qiagen, Hilden, Germany). The region in SIM1 was amplified by 
PCR under the following conditions: denaturation at 96 °C for 3 min, 
then 25 cycles of denaturation at 96 °C for 30 s, annealing at 56 °C 
for 15  s and elongation at 60 °C for 4  min, in the end followed by 
elongation at 72 °C for 10 min. We inspected the PCR products for the 
presence of single bands of the expected size on a 1% agarose gel and 
extracted them using the QIAquick Gel Extraction Kit (Qiagen).
Sequencing was performed on overlapping fragments (primer 
see Supplemental Table 2). The detected SIM1 variant was verified 
by reamplification and resequencing. Sequencing of the purified PCR 
products was performed using the ABI Prism sequence detector in 
combination with the Big Dye Terminator Cycle Sequencing Ready 
Reaction Kit (Applied Biosystems).
The rs3734354 genotype data for the extended cohort were 
derived from the HumanExome BeadChip v1.0 (Illumina, Inc., 
San Diego, CA, USA) using standard protocols suggested by the 
 manufacturer.
Statistical analyses
Statistical analyses were performed using the SPSS software package 
(version 17.0) (SPSS, Inc., Chicago, IL, USA). We used logistic regres-
sion to compare allelic frequencies between obese and lean healthy 
controls. To test for associations of genetic variants with binary obesity/
overweight and metabolic or anthropometric characteristics we applied 
generalized linear regression models under the additive mode of inher-
itance. All qualitative and quantitative analyses were adjusted for age, 
sex and pubertal stage. Pubertal stage was clinically assessed by Tan-
ner stage ranging from PH1 (=prepubertal) to PH5 (=adolescent, puberty 
completed). Hence, we regarded the PH as an ordinal variable. A p-value 
<0.05 was considered to provide nominal evidence for association.
Results
Screen for CNVs in severe obesity subset
We did not find CNVs in POMC, LEP, LEPR, MC4R, MC3R, 
MC2R or SIM1 in 194 obese children.
Initially, MLPA results indicated a homozygous SIM1 
exon 9 deletion in three cases and a heterozygous dele-
tion of the same exon in 49 cases (Figure 1). We then tried 
to validate this finding by PCR, which was, however, not 
indicative for deletions nor insertions or duplications 
large enough to be detected by agarose gel electrophoresis 
(Figure 2). Specifically, PCR products from samples for which 
MLPA indicated loss of one or both alleles were of equal 
size as the ones with the wild-type control (Figure  2). By 
Sanger sequencing of these fragments we found rs3734355 
(NM_005068.2:c.1112C>T, predicting amino acid substitution 
p.Ala371Val) to be located at the binding site of the MLPA 
SIM1 Exon 09A probe (Figure 3). This SNP was in complete 
linkage disequilibrium with rs3734354, which predicts a Pro-
352Thr change. The rs3734354 AA genotype corresponded 
in all three cases with the absence of a MLPA-signal, falsely 
indicating the absence of SIM1 copies and the AC-variant in 
49 cases corresponded with a blunted MLPA-signal, falsely 
indicating hemizygosity, whereas the CC-variant retained full 
MLPA-signal indicating the presence of two copies.
Hence, we did not find CNV in any of the obesity can-
didate genes investigated, but found a frequent SNP in 
SIM1 in our subset. 
Association of SIM1 genetic variant 
with childhood obesity
To investigate the role of the polymorphisms we used the 
exome chip data of all 194 cases and additional 880 obese 
and overweight children and 1231 lean children. We found 
rs3734354/rs3734355 to be associated with binary obesity/
overweight (see Table 3) and concordantly after applying 
linear regression under the additive model, to be associated 
with BMI-SDS (p = 0.003, adjusted to age, sex and pubertal 
state), and nominally with height SDS (p = 0.04). We did not 
find an association with further parameters of obesity such 
as waist-to-hip ratio, pubertal state, leptin levels, the SDS cor-
rected blood pressure or parameters of insulin homeostasis.
Furthermore we did not observe any association with 
quantity and quality of food intake of the patients, e.g. calo-
ries intake, intake of proteins, fats, carbohydrates and fiber 
(see Table 4). Other 13 variants of SIM1 on the exome chip 
were either not polymorphic in the probands tested in our 
study or were not analyzed due to low frequency.
Discussion
In this study, we aimed to investigate the role of CNVs 
in childhood obesity. We concentrated on “classical” 
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monogenic obesity genes, in which lack of one DNA strand 
may not have been detectable in conventional sequencing. 
The MLPA probes we used are set around genes that inter-
act with the regulation of the leptin-melanocortin system: 
leptin, being mainly synthesized in adipocytes, acts at the 
hypothalamus and interacts with neuropeptide Y/agouti 
related peptide (AGRP) and POMC neurons [27]. Both 
influence the energy balance. POMC neurons secrete the 
α-melanocyte stimulating hormone (α-MSH) which binds 
the melanocortin receptors (MC3R, MC4R) in the para-
ventricular nucleus and ventromedial hypothalamus [28]. 
Deficiency in MC4R resulted in hypertrophy of adipose 
tissue, dramatically increased body weight and hyperin-
sulinemia in mice [29]. Although MC2R is not considered 
a monogenetic obesity gene, we included it in our study 
as previous findings have shown its important role in the 
hypothalamic-pituitary-adrenal axis [30]. SIM1, instead, is 
Figure 2: Agarose gel electrophoresis of the PCR amplifications  
of SIM1, covering the binding site of the exon 9 MLPA probe.
The first band is a reference ladder with the 1 kb position being 
marked. Second band is a reference positive control containing  
two copies of SIM1 exon 9, bands 3–10 are amplicon one homozy-
gous and heterozygous samples showing same size as the positive 
control, hence lack of partial deletion, band 11 is a non-template 
control. For further information on primer location see Supplement 
Figure 1.
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Figure 1: Overview of MLPA-results.
Left panel: copy number signals of the SIM1 probe (“SIM1 exon 09A”) for all patients coded in colors. A green stripe represents one patient 
with two gene copies; yellow a heterozygous deletion; red a homozygous deletion. n = 194. Right panel: overlay of two MLPA result charts. 
Y-axis: number of gene copies. X-axis: regions of the binding probe. The arrow shows a sample with one missing SIM1 copy, for the light 
gray control the copy is present.
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a transcriptional factor expressed in the central nervous 
system that plays a role in the development and function 
of the hypothalamus [31]. Its influence on obesity has pre-
viously been demonstrated in knock-out mice: while SIM1 
homozygous null mice die shortly after birth, heterozygous 
mice survive and develop early-onset obesity and hyper-
phagia [32]. In humans, Varela et  al. were able to find a 
deletion in SIM1 in one patient who presented not only 
with learning disability and hypotonia but also with hyper-
phagia and obesity [33]. Altogether we hypothesized that 
deficiencies or duplications in those genes may influence 
the BMI through direct or indirect interactions with the lep-
tin-melanocortin system [34]. As described above common 
SNPs identified by GWAS could so far explain only a small 
percentage of inherited obesity. Recently focus shifted 
towards CNVs, revealing rare variants that influence the 
leptin-melanocortin system [35]. We expected that CNVs 
in our selected genes will have an effect on BMI and other 
parameters of obesity that will appear more evidently and 
early in severely obese children.
To investigate the presence of CNVs, we performed 
a copy number quantification in our cohort of extremely 
obese children with BMI > 2.2 SDS and up to 4.2 SDS. 
After verifying our data, all our patients had two copies 
of the analyzed sections of genes. Previous studies with 
similar approaches show ambiguous results: Gless-
ner et  al. identified several CNVs in obese children and 
controls by deriving common CNVs from SNP data [36]. 
C C C C C CCG G A T T T T TT G nG
80 90
Figure 3: Heterozygous variant of rs3734354.
Sequence of the rs3734354 region showing two dyes at the same position indicating a heterozygous polymorphism in one of our patients 
with a MLPA signal suggestive for loss of one SIM1 exon 9 copy.
Table 3: Cross tables of rs3734354 genotype and binary overweight/obesity with according odds ratios (95% KI) and p-values.
CC AC AA Total OR [95% C.I.] p-Value
Count % Count % Count % Count %
Lean 877 52.5 317 54.6 35 70.0 1229 53.4 0.93 [0.88 ± 0.99] 0.014
Overweight and obese 794 47.5 264 45.4 15 30.0 1073 46.6
Total 1671 100.0 581 100.0 50 100.0 2302 100.0
Lean 877 59.4 317 60.4 35 71.4 1229 59.9 0.95 [0.90 ± 1.01] 0.095
Obese 600 40.6 208 39.6 14 28.6 822 40.1
Total 1477 100.0 525 100.0 49 100.0 2051 100.0
Lean is defined as BMI below 1.23 SDS, overweight as BMI between 1.23 and 1.88 SDS, obese as BMI above 1.88 SDS; OR is odds ratio with 
95% confidence interval given in square brackets; p and OR are given after logistic regression for binary obesity ± overweight in the additive 
mode of inheritance, adjusted to age, sex and pubertal stage.
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Zhang et al. investigated the interactions of common CNVs 
and dietary behavior in children using the AccuCopy® 
assay (Genesky BioTech, Shanghai, China), similar to our 
multiplex reaction, but focused on other gene loci [37]. 
They found three loci to be significantly associated with 
obesity (10q11.22, 4q25 and 11q11). Interestingly in this 
study, a meat diet increased the odds ratio (OR) of obesity 
for one deletion, while for another deletion and duplica-
tion this was done by salty food – showing complex mul-
tiplicative interactions.
We are aware of the limitations posed by the method 
we used: as MLPA probes cover only a part of the gene, 
short regions which might contain CNV remain unexam-
ined, as well as SNPs causing a gain or loss of function 
are usually not detectable with MLPA. Also the use of 
predesigned probes in commercial kits limits the selec-
tion of genes. Genes that are both associated with obesity 
and interact with the hypothalamic regulation of energy 
intake like PCKS1 [38] (that performs the proteolytic cleav-
age of POMC) [39] and MRAP2 (that enhances cAMP sign-
aling through MC4R) [40] are interesting candidates for 
further CNV studies. Furthermore, we acknowledge the 
number of examined patients is rather low and larger 
cohorts (n > 1000) would be desirable to increase the odds 
of detecting CNVs associated with severe obesity.
In addition to this, SNPs like rs3734354/5 can influ-
ence the binding characteristics of the MLPA-probe to 
deliver a false result. As we found rs3734354 altered in 
>25% of our extremely obese children, we wanted to 
further evaluate its effects in a larger cohort of obese chil-
dren compared to lean control children. In our extended 
cohort of 2305 children we verified an association of 
rs3734354 with BMI-SDS (p = 0.003; B = −0.06). Carriers of 
the rare “AA” variant were not only less prone to obesity 
but also had a lower height (height SDS: B = −0.04, 
p = 0.04). Yet no associations with other parameters of 
obesity or metabolic deregulation were found, neither 
did different variants of the SNP influence blood pressure 
nor show interaction with a specific diet. It is, however, 
noteworthy that according to our data the minor allele of 
rs3734354 is protective from obesity in our cohort of chil-
dren. In previous studies the effects of rs3734354/5 were 
either inconclusive or contrary: a study on 3.479 adults 
found rs3734354 associated with higher BMI [41] while 
Ghoussaini et al. performed an analysis on 3.248 obese 
and lean adults and children (mean age 11 and 41, 
Table 4: Metabolic characteristics stratified for the gene variants of rs3734354 (±SEM) and according effect sizes and p-values.
rs3734354   n  CC (n = 1673)  AC (n = 582)  AA (n = 50)  β  p-Value
Parameters of obesity
 BMI-SDS   2302  1.01 ± 0.04  1 ± 0.06  0.37 ± 0.22  −0.06  0.003
 Sex   2305  0.49 ± 0.01  0.48 ± 0.02  0.44 ± 0.07  −0.02  0.35
 Age   2305  11.33 ± 0.08  11.33 ± 0.14  11.39 ± 0.53  0.007  0.59
 Height SDS   2300  0.34 ± 0.03  0.37 ± 0.05  −0.05 ± 0.17  −0.04  0.04
 Waist-to-hip ratio   2024  0.85 ± 0.002  0.85 ± 0.004  0.85 ± 0.02  0.01  0.58
 Pubertal state   2280  2.53 ± 0.04  2.53 ± 0.07  2.48 ± 0.25  −0.008  0.53
 Birth weight, g   1054  3387 ± 24  3455 ± 39  3289 ± 174  −0.001  0.97
 Leptin   730  22 ± 0.7  24 ± 1.5  21 ± 4.1  −0.003  0.93
Insulin homeostasis
 FBG, mmol/L   778  4.66 ± 0.02  4.59 ± 0.04  4.56 ± 0.1  −0.03  0.36
 120 min BG, mmol/L   916  5.96 ± 0.04  6.05 ± 0.09  5.44 ± 0.23  −0.05  0.16
 FPI, pmol/L   765  133 ± 7  137 ± 14  111 ± 23  −0.01  0.71
 120 min Insulin, pmol/L   898  636 ± 30  765 ± 71  482 ± 106  −0.008  0.8
 HOMA   903  2.87 ± 0.1  2.9 ± 0.15  2.49 ± 0.47  −0.02  0.57
 HbA1c   821  5.37 ± 0.01  5.42 ± 0.02  5.46 ± 0.07  0.04  0.23
RR
 Systolic RR SDS, mmHg   2180  0.95 ± 0.03  0.93 ± 0.05  0.67 ± 0.19  −0.03  0.14
 Diastolic RR SDS, mmHg  2180  0.6 ± 0.02  0.64 ± 0.03  0.53 ± 0.13  −0.004  0.84
Food intake
 Energy, kcal   153  2065 ± 51  2056 ± 81  1659 ± 754  −0.05  0.51
 Protein, g   153  71 ± 1.9  70 ± 3.2  50 ± 25.1  −0.08  0.28
 Fat, g   153  81 ± 2.5  80 ± 4  59 ± 17.6  −0.07  0.37
 Carbohydrates, g   153  254 ± 7  254 ± 11  225 ± 118  −0.02  0.83
 Fiber, g   153  16.78 ± 0.5  17.64 ± 1.23  15.49 ± 4.86  0.02  0.84
All data is adjusted to age, sex and pubertal state. β is non-standardized per-allele beta (SE) in the additive model and refers to the major 
allele. FBG, fasting blood glucose; BG, blood glucose; FPI, fasting plasma insulin; HOMA, homeostatic model assessment; RR, blood pressure.
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respectively) detecting a nominal association (p = 0.01) 
with parameters of obesity [42]. A study in Pima Indians 
found rs3734354/5 not to be associated with BMI [43]. 
Other rare as well as common variants in SIM1 have been 
discovered as important risk factors for obesity [44, 45] 
underlining the significance of SIM1 in energy homeosta-
sis. It has been discussed that the incoherent association 
with BMI described above is age dependent and may not 
become apparent “until well into middle age” [41]. Our 
data suggest that variations of rs3734354 interact with 
obesity of early-onset type in children and have meas-
urable effects at an early age already. The pathomecha-
nism of these interactions is mostly unknown. It remains 
unclear why adult carriers of the rs3734354 minor allele 
develop a higher BMI, whereas in children it seems to be 
protective from obesity. In their previously mentioned 
study Swarbrick et  al. could show that rs3734354/5 can 
impair SIM1’s ability to activate target gene transcription 
[41]. In mice SIM1 itself was found to be expressed in the 
paraventricular and supraoptic nuclei, the amygdala and 
lateral hypothalamus [46], areas broadly associated with 
regulation of energy balance. It is likely that SIM1 regu-
lates the expression of specific peptides like corticotro-
pin-releasing hormone (CRH), oxytocin or somatostatin 
in the paraventricular nuclei and thus modulate feeding 
and fasting. This process as well as the transcription acti-
vation of target genes needs better understanding.
We found rs3734354 to interfere with one SIM1 MLPA 
probe on exon 9 causing a non-ligation pretending a dele-
tion. MRC-Holland updated specifications of the used kit 
number 220 and later removed the concerned probe. As our 
study was performed with children, it has to be taken into 
account that a variant-effect can manifest in later stages of 
life and is possibly modified by gene-environment inter-
actions – therefore not being detectable or being only 
detectable with advanced stages of disease, which are less 
prevalent in children. Also our study was carried out in a 
cohort enriched in obesity cases compared to the general 
pediatric population. Studying a secondary outcome in a 
population ascertained for a primary outcome can intro-
duce a bias in the estimation of the effect.
In summary, we were unable to find CNVs in well-
established obesity genes POMC, LEP, LEPR, MC4R, MC3R 
and SIM1 in our modest sample of severely obese children. 
Nevertheless, we found an association of rs3734354 with 
obesity of early-onset type in children, although not with 
obesity-related traits.
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